, Agency for Toxic Substances and Disease Registry (ATSDR), 2002.

E. D. Albrecht and G. J. Pepe, Estrogen regulation of placental angiogenesis and fetal ovarian 613 development during primate pregnancy, The International journal of developmental biology, vol.614, pp.397-408, 2010.

P. Allison, Convergence failures in logistic regression, SAS Global Forum, vol.616, pp.1-11, 2008.

L. Alvarez, S. Hernandez, R. Martinez-de-mena, R. Kolliker-frers, and M. J. Obregon, , p.618

D. L. Pisarev, The role of type i and type ii 5' deiodinases on hexachlorobenzene-induced 619 alteration of the hormonal thyroid status, Toxicology, vol.207, pp.349-362, 2005.

A. Network, Neonatal morphometrics curves, 2008.

C. C. Bach, B. H. Bech, N. Brix, E. A. Nohr, J. P. Bonde et al., Perfluoroalkyl and 623 polyfluoroalkyl substances and human fetal growth: A systematic review, Crit Rev Toxicol, vol.624, pp.53-67, 2015.

B. A. Bailey and A. R. Byrom, Factors predicting birth weight in a low-risk sample: The role 626 of modifiable pregnancy health behaviors, Matern Child Health J, vol.11, pp.173-179, 2007.

D. J. Barker, P. D. Winter, C. Osmond, B. Margetts, and S. J. Simmonds, Weight in infancy and 628 death from ischaemic heart disease, Lancet, vol.2, pp.577-580, 1989.

D. J. Barker, In utero programming of chronic disease, Clin Sci (Lond), vol.95, pp.115-128, 1998.

M. Basterrechea, A. Lertxundi, C. Iniguez, M. Mendez, M. Murcia et al., Prenatal, vol.631, 2014.

M. Casas, M. Nieuwenhuijsen, D. Martinez, F. Ballester, X. Basagana et al.,

, Prenatal exposure to pcb-153, p,p'-dde and birth outcomes in 9000 mother-child pairs, p.645, 2015.

, Exposure-response relationship and effect modifiers, Environ Int, vol.74, pp.23-31

A. O. Cheek, K. Kow, J. Chen, and J. A. Mclachlan, Potential mechanisms of thyroid disruption 647 in humans: Interaction of organochlorine compounds with thyroid receptor, transthyretin, and 648 thyroid-binding globulin, Environ Health Perspect, vol.107, pp.273-278, 1999.

M. De-cock and M. Van-de-bor, Obesogenic effects of endocrine disruptors, what do we 650 know from animal and human studies?, Environ Int, vol.70, pp.15-24, 2014.

E. Diamanti-kandarakis, J. P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins et al.,

, Endocrine-disrupting chemicals: An endocrine society scientific statement, Endocr Rev, vol.653, pp.293-342, 2009.

M. Eggesbo, H. Stigum, M. P. Longnecker, A. Polder, M. Aldrin et al., Levels of 655 hexachlorobenzene (hcb) in breast milk in relation to birth, 2009.

, Environ Res, vol.109, pp.559-566

E. , European perinatal health report. Health and care of pregnant 658 women and babies in europe in, 2010.

C. P. Ferreira, A. C. De-oliveira, and F. J. Paumgartten, Serum concentrations of ddt and dde 660 among malaria control workers in the amazon region, J Occup Health, vol.53, pp.115-122, 2011.

B. C. Gladen, Z. A. Shkiryak-nyzhnyk, N. Chyslovska, and T. D. Zadorozhnaja, , 2003.

, Persistent organochlorine compounds and birth weight, Ann Epidemiol, vol.13, pp.151-157

R. L. Goldenberg, S. P. Cliver, Y. Neggers, R. L. Copper, M. D. Dubard et al., The 664 relationship between maternal characteristics and fetal and neonatal anthropometric 665 measurements in women delivering at term: A summary, Acta Obstet Gynecol Scand Suppl, vol.666, pp.8-13, 1997.

E. Govarts, M. Nieuwenhuijsen, G. Schoeters, F. Ballester, K. Bloemen et al., , p.668, 2012.